# LACOSAMIDE
> **ANDA216335** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2022-09-14
## Drug
- **FDA Application Number:** ANDA216335
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LACOSAMIDE
- **Generic name:** LACOSAMIDE
- **Active ingredients:** LACOSAMIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **Manufacturer:** XLCare Pharmaceuticals Inc.
- **First approval:** 2022-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216335)
---
*MORVS · CC0 1.0*